Kuvatris Therapeutics, Inc.
PXMDDelisted Aug 8, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001811623
Kuvatris Therapeutics, Inc. was delisted on Aug 8, 2025; its insiders filed their last Form 4 on Mar 14, 2024; no institution reported holding it in 13F filings for Q2 2025; no superinvestor held it.
Q2 2024 vs. Q1 2024
How the institutions holding Kuvatris Therapeutics, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 8 | 1 | −7 |
| Shares | 127.0K | 58 | −127.0K (−100.0%) |
| Value | $64.7K | $12 | −$64.7K (−100.0%) |
New holders (0)
Institutions that held Kuvatris Therapeutics, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
None.
Sold out (7)
Institutions that held Kuvatris Therapeutics, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Souders Financial Advisors | 40,000 | $20.4K |
| Virtu Financial LLC | 37,315 | $19.0K |
| Susquehanna International Group, LLP | 26,091 | $13.3K |
| Two Sigma Securities, LLC | 16,491 | $8.41K |
| Tower Research Capital LLC (TRC) | 7,023 | $3.58K |
| Wells Fargo & Company | 30 | $15 |
| Clearstead Advisors, LLC | 1 | $1 |